Certara
-

Radnor Drug Designer Certara Sells Medical Writing Business
Radnor-based drug developer Certara is selling its regulatory and medical writing business for up to $135 million to Veristat, writes John George for Philadelphia Business…
-

Certara Moves Corporate Headquarters From Princeton to Radnor
Certara, a technology company that specializes in biosimulation software which helps with drug discovery and development, has moved its corporate headquarters to Radnor, writes John…




















